Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Calcineurin activity

Known as: calcineurin, protein phosphatase type 2B activity 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND Therapeutic drug monitoring of calcineurin inhibitor, tacrolimus (TAC), is routinely used in post-transplantation… Expand
2018
2018
High CNI IPV has been associated with poor kidney allograft outcomes, albeit in small limited studies.We evaluated effect of CNI… Expand
2015
2015
Calcineurin (CN) is the target of the immunophilin-immunosuppressant complex, cyclophilin/cyclosporin A (CyP/CsA). RCAN1 has… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2014
2014
The aims of this population‐pharmacokinetic/pharmacodynamic (POP‐PKPD) analysis of voclosporin in renal allograft patients were… Expand
2013
2013
In Down syndrome (DS), trisomy 21 leads to overexpression of gene coding for specific enzymes. This overexpression translates… Expand
  • figure 1
  • table 1
  • table 2
2008
2008
Recent reports on the involvement of calcineurin in cardiac hypertrophy and its susceptibility to free radicals, prompted us to… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
2008
2008
During the early post-transplantation period, the limitations of monitoring current tacrolimus dose with classic pharmacokinetics… Expand
Highly Cited
2004
Highly Cited
2004
Utrophin has been studied extensively in recent years in an effort to find a cure for Duchenne muscular dystrophy. In this… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2004
2004
BACKGROUND There is a correlation between cyclosporine (CsA) pharmacokinetics (PK) and pharmacodynamics (PD), especially 2 hours… Expand
Highly Cited
2003
Highly Cited
2003
BACKGROUND Graft survival depends on adequate immunosuppression. To evaluate the effect on the immune system of immunosuppressive… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4